AVTX insider exercise and 10b5-1 sales disclosed

AVTX reported proposed transactions relating to company common stock.

Rhea-AI Filing Summary

AVTX reported proposed transactions relating to company common stock. The filing lists an exercise of stock options for 47,000 shares on 05/06/2026 (cash to issuer) and records recent 10b5-1 sales of 8,457, 8,458, 7,980, and 7,979 shares on 04/30/2026, 04/29/2026, 04/02/2026, and 04/01/2026 respectively, with dollar proceeds shown for each sale.

Insights

Corporate Governance Analyst

Insider transactions are routine exercise-and-sale activity under a trading plan.

The filing documents an exercise of stock options for 47,000 shares on 05/06/2026, labeled as paid in cash to the issuer. Several prior days show 10b5-1 sales totaling mid-single‑digit thousands of shares per trade, each with an explicit dollar amount.

These entries are transactional disclosures; cash flow appears to go to/from the issuer for the exercise and to the reporting person for the executed sales. Timing and plan mechanics are shown by the 10b5-1 label.

Key Figures

Option exercise shares: 47,000 shares 10b5-1 sale 04/30/2026: 8,457 shares 10b5-1 sale 04/29/2026: 8,458 shares +2 more

5 metrics

Option exercise shares 47,000 shares Exercise of Stock Options on 05/06/2026

10b5-1 sale 04/30/2026 8,457 shares Proceeds <money>$111,853.13</money>

10b5-1 sale 04/29/2026 8,458 shares Proceeds <money>$110,736.37</money>

10b5-1 sale 04/02/2026 7,980 shares Proceeds <money>$136,822.69</money>

10b5-1 sale 04/01/2026 7,979 shares Proceeds <money>$133,770.33</money>

Key Terms

10b5-1, Exercise of Stock Options, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for CHRISTOPHER SULLIVAN ..."

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold | ... | Exercise of Stock Options |"

Form 144 regulatory

"Filer Information ... 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AVTX's Form 144 show about the 47,000 shares?

It shows an exercise of stock options for 47,000 shares on 05/06/2026. The filing lists the exercise as paid in cash to the issuer, indicating option conversion rather than an open-market purchase.

Who executed the recent 10b5-1 sales shown in the filing for AVTX?

The filing attributes multiple 10b5-1 sales to Christopher Sullivan on specific dates. Each sale lists share counts and dollar proceeds, indicating automated plan trades rather than ad hoc open-market sales.

How many shares were sold under the 10b5-1 trades and what proceeds were shown?

The filing lists four trades: 8,457 ($111,853.13), 8,458 ($110,736.37), 7,980 ($136,822.69), and 7,979 ($133,770.33). Each amount appears next to its trade date.

Does the Form 144 indicate who receives the exercise proceeds for AVTX?

Yes; the exercise row is labeled with Issuer and Cash, indicating cash consideration associated with the option exercise goes to the issuer as shown in the filing.

Are the 10b5-1 sales described in AVTX's filing discretionary trades?

The sales are labeled 10b5-1, which denotes trades executed under a pre-arranged trading plan. The filing text shows that description but does not provide the plan adoption date or further mechanics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/06/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001810417
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AVALO THERAPEUTICS, INC.
SEC File Number	001-37590
Address of Issuer	1500 Liberty Ridge Drive, Suite 321 Wayne PENNSYLVANIA 19087
Phone	4105228707
Name of Person for Whose Account the Securities are To Be Sold	CHRISTOPHER SULLIVAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	47000	764220.00	22788452	05/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/06/2026	Exercise of Stock Options	Issuer			47000	05/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTOPHER SULLIVAN 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	04/30/2026	8457	111853.13
10b5-1 Sales for CHRISTOPHER SULLIVAN 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	04/29/2026	8458	110736.37
10b5-1 Sales for CHRISTOPHER SULLIVAN 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	04/02/2026	7980	136822.69
10b5-1 Sales for CHRISTOPHER SULLIVAN 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	04/01/2026	7979	133770.33

144: Remarks and Signature

Remarks
Date of Notice	05/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christopher Sullivan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)